| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.84▼ | 2.86▼ | 2.85▼ | 2.67▲ | 2.55▲ |
| MA10 | 2.86▼ | 2.86▼ | 2.75▲ | 2.74▲ | 2.16▲ |
| MA20 | 2.87▼ | 2.74▲ | 2.68▲ | 2.37▲ | 1.88▲ |
| MA50 | 2.86▼ | 2.69▲ | 2.81▼ | 1.99▲ | 2.25▲ |
| MA100 | 2.76▲ | 2.81▼ | 2.62▲ | 1.73▲ | 7.58▼ |
| MA200 | 2.68▲ | 2.55▲ | 2.23▲ | 1.42▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.010▼ | 0.011▲ | 0.034▲ | 0.003▲ | 0.248▲ |
| RSI | 33.331▼ | 54.069▲ | 54.402▲ | 63.853▲ | 58.502▲ |
| STOCH | 15.344▼ | 70.959 | 86.731▲ | 49.914 | 74.829 |
| WILL %R | -100.000▼ | -33.333 | -24.510▲ | -28.889 | -24.462▲ |
| CCI | -178.277▼ | 10.404 | 63.448 | 45.009 | 133.152▲ |
|
Thursday, November 06, 2025 04:13 AM
Announced class-leading data from diet-induced obesity (DIO) mouse model with NMRA-215, a potentially best-in-class, highly brain-penetrant, oral ...
|
|
Monday, November 03, 2025 02:00 AM
Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven programs that target novel mechanisms of ...
|
|
Friday, October 31, 2025 12:01 AM
Neumora Therapeutics (NMRA) shares drew fresh attention after the company announced two advances in its clinical pipeline. The launch of a Phase 1 trial for NMRA-898 and new preclinical results for ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/11/25 | 2.57 | 2.92 | 2.55 | 2.795 | 1,635,824 |
| 07/11/25 | 2.50 | 2.635 | 2.40 | 2.56 | 1,214,668 |
| 06/11/25 | 2.39 | 2.7511 | 2.345 | 2.58 | 2,275,047 |
| 05/11/25 | 2.79 | 2.878 | 2.62 | 2.62 | 1,652,650 |
| 04/11/25 | 2.91 | 2.955 | 2.7201 | 2.79 | 2,304,122 |
| 03/11/25 | 3.03 | 3.0604 | 2.82 | 3.01 | 1,824,718 |
| 31/10/25 | 3.00 | 3.25 | 2.82 | 3.02 | 4,581,769 |
| 30/10/25 | 2.75 | 3.045 | 2.67 | 2.93 | 7,494,385 |
| 29/10/25 | 2.60 | 2.69 | 2.40 | 2.50 | 4,153,081 |
| 28/10/25 | 2.70 | 2.70 | 2.56 | 2.59 | 1,397,251 |
|
|
||||
|
|
||||
|
|